Not Medicare Enrolled

Dr. Steve Frost, M.D.

Urology Physician · Dallas, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3417 GASTON AVE, Dallas, TX 75246
2148266021
In practice since 2006 (19 years)
NPI: 1497794663 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Frost from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Frost? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Frost

Dr. Steve Frost is an urology physician in Dallas, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Frost performed 2,169 Medicare services across 1,381 unique beneficiaries.

Between the years covered by Open Payments, Dr. Frost received a total of $5,763 from 53 pharmaceutical and/or device companies across 326 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Frost is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 46% volume in TX $5,763 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,169
Medicare services
Top 46% in TX for urology physician
1,381
Unique beneficiaries
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~114 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Urinalysis with microscopic exam
A urine test performed manually that includes examining the sample under a microscope to check for abnormalities.
516 $3 $6
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
368 $61 $183
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
360 $46 $127
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
178 $8 $17
PSA test (prostate cancer screening) 164 $18 $37
Chronic care management, additional 20 min/month
This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month.
100 $38 $96
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
99 $37 $115
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
89 $8 $22
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
41 $79 $226
Urine culture, bacterial identification
A laboratory test that grows and identifies bacteria from a urine sample to detect infections.
39 $8 $16
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
35 $187 $494
Urine culture, bacterial colony count
A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections.
35 $8 $16
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
35 $88 $259
Bacterial culture, aerobic
A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms.
28 $8 $16
Antibiotic sensitivity test
A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods.
28 $8 $17
Free PSA test
A blood test that measures the amount of unbound prostate-specific antigen in the blood.
22 $18 $37
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
21 $28 $70
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
11 $2 $5
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,763
Total received (2018-2024)
Avg $823/year across 7 years
Top 34% in TX for urology physician
53
Companies
326
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,664 (98.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$100 (1.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$40
2023
$758
2022
$1,290
2021
$590
2020
$314
2019
$1,278
2018
$1,493

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$1,091
Janssen Biotech, Inc.
$570
Bayer HealthCare Pharmaceuticals Inc.
$402
Endo Pharmaceuticals Inc.
$326
Dendreon Pharmaceuticals LLC
$278
Boston Scientific Corporation
$260
Blue Earth Diagnostics Limited
$234
ABBVIE INC.
$158
Amgen Inc.
$141
UroGen Pharma, Inc.
$125
Sun Pharmaceutical Industries Inc.
$115
Coloplast Corp
$112
PFIZER INC.
$110
Sumitomo Pharma America, Inc.
$107
AbbVie, Inc.
$97
Retrophin, Inc.
$89
Myovant Sciences Inc.
$88
UROVANT SCIENCES INC
$87
Ferring Pharmaceuticals Inc.
$86
Mallinckrodt LLC
$84
TOLMAR Pharmaceuticals, Inc.
$78
Antares Pharma, Inc.
$75
Novartis Pharmaceuticals Corporation
$74
Agiliti Surgical, Inc.
$64
BOSTON SCIENTIFIC CORPORATION
$62
Foundation Medicine, Inc.
$59
C. R. Bard, Inc. & Subsidiaries
$58
Allergan Inc.
$55
BioTissue Holdings, Inc.
$54
Mallinckrodt Enterprises LLC
$51
Axonics, Inc.
$46
Ethicon US, LLC
$45
Progenics Pharmaceuticals, Inc.
$42
MEDIVATION FIELD SOLUTIONS LLC
$38
Avadel Specialty Pharmaceuticals, LLC
$36
Lantheus Medical Imaging, Inc.
$32
Merck Sharp & Dohme LLC
$31
Aytu BioScience, Inc
$29
Medtronic, Inc.
$29
Janssen Scientific Affairs, LLC
$27
SUN PHARMACEUTICAL INDUSTRIES INC.
$25
Laborie Medical Technologies Corp.
$22
Bayer Healthcare Pharmaceuticals Inc.
$21
Mallinckrodt Hospital Products Inc.
$20
AstraZeneca Pharmaceuticals LP
$18
Metuchen Pharmaceuticals
$17
NeoTract Inc.
$15
Olympus America Inc.
$15
Myriad Genetic Laboratories, Inc.
$15
Teleflex LLC
$13
Allergan, Inc.
$12
Cook Medical LLC
$12
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 35.8% of total payments
Associated products mentioned in payments ›
(815) Thiola · ADVANTAGE FIT · AMS · Androgel · Axonics · Axumin · BOTOX · BOTOX THERAPEUTIC · CLENPIQ · Cook Medical Biopsy · EDEX · ELIGARD · ERLEADA · EXPAND 212 · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · GENERAL BPH · GENERAL - BPH · General - Vascular Access · GreenLight XPS · JELMYTO · KEYTRUDA · LIGASURE · LITHOVUE · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lupron Depot · MYRBETRIQ · Myrbetriq · NEOX · NOCDURNA · Natesto · Noctiva · Nubeqa · OFIRMEV · ORGOVYX · OTREXUP · Olympus Guidewires · Otrexup · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Prineo 42 · Prolia · Quadramet · REZUM · SIGNIA · SURGICEL Family of Absorbable Hemostats · SpaceOAR VUE System - 10mL · Stendra · TITAN · Titan · UroLift · UroLift System · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $266 per 100 Medicare services performed
Looking for an urology physician in Dallas?
Compare urology physicians in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
149
Per 100K population
5.7
County median income
$74,149
Nearest hospital
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Frost is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Frost experienced with urinalysis with microscopic exam?
Based on Medicare claims data, Dr. Frost performed 516 urinalysis with microscopic exam services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Frost receive payments from pharmaceutical companies?
Yes. Dr. Frost received a total of $5,763 from 53 companies across 326 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Frost's costs compare to other urology physicians in Dallas?
Dr. Frost's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Frost) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →